05q3

Targeting Trends Newsletter 05q3

Below are links to view the quarterly newsletter Targeting Trends. If you would like to be added to the mailing list, please complete the information on our contact page. Newsletter Highlights ATS visits USS Asheville (page 2) Teaser Winners (page 2) SP-SAP therapeutic update (page 6) SSTr1, SSTr5 and NK-1r Antibodies (page 7) Page 1 Page …

Targeting Trends Newsletter 05q3 Read More »

Targeting Tools: SSTr1, SSTr5, NK-1r

Advanced Targeting Systems announces three new antibodies to G protein-coupled receptors that will be quite helpful for a number of researchers studying somatostatin and substance P. For somatostatin study, we already market excellent rabbit polyclonals to somatostatin-14 (Cat. #AB-04) and somatostatin-28 (Cat. #AB-05). We now announce a new mouse monoclonal antibody to somatostatin receptor 1 …

Targeting Tools: SSTr1, SSTr5, NK-1r Read More »

Targeting Talk: Saporin Safety

You have stated previously in Targeting Trends (see Jul-Aug-Sep, 2001) that it was unlikely that saporin compounds or constituents would be excreted in urine or feces. However, you acknowledge that experimental data is lacking. Have there been any tests of animal urine or feces for saporin content? My animal care staff are concerned. One of …

Targeting Talk: Saporin Safety Read More »

Targeting Topics 05q3

CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma. Duxbury MS, Ito H, Ashley SW, Whang EE. Biochem Biophys Res Commun 317(3):837-843, 2004. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is a cell-surface molecule that is overexpressed in a variety of human cancers. Here, the authors investigate the efficacy of …

Targeting Topics 05q3 Read More »